Who Paid My Doc
Sarit Vaserman
Clinical Nurse Specialist, Family Health Raleigh, NC Nurse Practitioner
NPI 1154725604 CMS profile 10468033
3404 Wake Forest Rd, Bldg 7, Raleigh, NC 27609
General payments
$800
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Sarit Vaserman of Raleigh, NC is reported in the CMS Open Payments database as having received $800 across 9 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 65th percentile of Clinical Nurse Specialist, Family Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $86 | 1 | |
| 2021 | General | $714 | 8 |
Beside peers
- Sarit Vaserman
- Clinical Nurse Specialist, Family Health median
- Middle half of Clinical Nurse Specialist, Family Health
- National median
In program year 2025, general payments to Sarit Vaserman were reported at $0. Among 164 Clinical Nurse Specialist, Family Health profiles paid that year, the median was $216 and the middle half received between $57 and $492.
Show as a table
| Year | Sarit Vaserman | Clinical Nurse Specialist, Family Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $714 | $151 | $46–$400 | $132 |
| 2022 | $86 | $153 | $37–$527 | $149 |
| 2023 | $0 | $139 | $50–$451 | $160 |
| 2024 | $0 | $150 | $46–$571 | $164 |
| 2025 | $0 | $216 | $57–$492 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
68
Drug cost
$36,278
Branded share of claims
77.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 38 | $27,792 | |
| Xarelto Rivaroxaban | Brand | 15 | $8,432 | |
| Folic Acid | Generic | 15 | $54 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 9 billing codesPaid by Medicare
$9,789
Medicare patients
100
Services billed
213
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 55% | |
| Diabetes | 42% | |
| Chronic kidney disease | 42% | |
| Ischemic heart disease | 33% | |
| Depression | 31% | |
| Heart failure | 29% | |
| Atrial fibrillation | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
9 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Family Health in North Carolina
Related records
Clinical Nurse Specialist, Family Health in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Family Health
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.